Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Fengyi Mao
Plk1 Inhibition Enhances the Efficacy of BET Epigenetic Reader Blockade in Castration-Resistant Prostate Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Inhibition of Polo-Like Kinase 1 (Plk1) Enhances the Antineoplastic Activity of Metformin in Prostate Cancer
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Inhibition of LOXL2 Enhances the Radiosensitivity of Castration-Resistant Prostate Cancer Cells Associated With the Reversal of the EMT Process
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Epigenetic Therapy With Panobinostat Combined With Bicalutamide Re-Challenge in Castration-Resistant Prostate Cancer
Clinical Cancer Research
Cancer Research
Oncology
Visceral Disease in Castration-Resistant Prostate Cancer
European Urology
Urology
Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer
Yearbook of Paediatric Endocrinology
Abiraterone in Metastatic Castration-Resistant Prostate Cancer: Efficacy and Safety in Unselected Patients
Cancer Treatment and Research Communications
Cancer Research
Oncology
Aggressive Variants of Castration-Resistant Prostate Cancer
Clinical Cancer Research
Cancer Research
Oncology
Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer
Clinical Cancer Research
Cancer Research
Oncology
Pcn346 - Disease Specific Cost Analysis of the Nonmetastatic Castration-Resistant Prostate Cancer and Metastatic Castration-Resistant Prostate Cancer Health States
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
